Evidence map›Paper›PMID 26364278›Full record

ArticleTopics in spinal cord injury rehabilitation2015

Mobility Outcomes Following Five Training Sessions with a Powered Exoskeleton.

Clare Hartigan, Casey Kandilakis, Skyler Dalley, Mike Clausen, Edgar Wilson, Scott Morrison, Steven Etheridge, Ryan Farris

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Topics in spinal cord injury rehabilitation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04215081 (ExoAtlet II Lower Extremity Exoskeleton Safety and Efficacy Use With Spinal Cord Injured Individuals), which is not on this map. Cited by 65 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04215081 nacompletednot on this mapstarted 2019, after this paper: background citation

ExoAtlet II Lower Extremity Exoskeleton Safety and Efficacy Use With Spinal Cord Injured Individuals

TypeinterventionalSponsorCOSMO ROBOTICS CO., LtdRan2019 to 2020Enrolled20ConditionsSpinal Cord Injuries, ParaplegiaArmsGait training using ExoAtlet exoskeleton
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Clare HartiganVirginia C. Crawford Research Institute, Shepherd Center, Atlanta, Georgia.
Casey KandilakisVirginia C. Crawford Research Institute, Shepherd Center, Atlanta, Georgia.
Skyler DalleyParker Hannifin Corporation, Human Motion and Control, Macedonia, Ohio.
Mike ClausenParker Hannifin Corporation, Human Motion and Control, Macedonia, Ohio.
Edgar WilsonParker Hannifin Corporation, Human Motion and Control, Macedonia, Ohio.
Scott MorrisonParker Hannifin Corporation, Human Motion and Control, Macedonia, Ohio.
Steven EtheridgeParker Hannifin Corporation, Human Motion and Control, Macedonia, Ohio.
Ryan FarrisParker Hannifin Corporation, Human Motion and Control, Macedonia, Ohio.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLoss of legged mobility due to spinal cord injury (SCI) is associated with multiple physiological and psychological impacts. Powered exoskeletons offer the possibility of regained mobility and reversal or prevention of the secondary effects associated with immobility.

objectiveThis study was conducted to evaluate mobility outcomes for individuals with SCI after 5 gait-training sessions with a powered exoskeleton, with a primary goal of characterizing the ease of learning and usability of the system.

methodsSixteen subjects with SCI were enrolled in a pilot clinical trial at Shepherd Center, Atlanta, Georgia, with injury levels ranging from C5 complete to L1 incomplete. An investigational Indego exoskeleton research kit was evaluated for ease of use and efficacy in providing legged mobility. Outcome measures of the study included the 10-meter walk test (10 MWT) and the 6-minute walk test (6 MWT) as well as measures of independence including donning and doffing times and the ability to walk on various surfaces.

resultsAt the end of 5 sessions (1.5 hours per session), average walking speed was 0.22 m/s for persons with C5-6 motor complete tetraplegia, 0.26 m/s for T1-8 motor complete paraplegia, and 0.45 m/s for T9-L1 paraplegia. Distances covered in 6 minutes averaged 64 meters for those with C5-6, 74 meters for T1-8, and 121 meters for T9-L1. Additionally, all participants were able to walk on both indoor and outdoor surfaces.

conclusionsResults after only 5 sessions suggest that persons with tetraplegia and paraplegia learn to use the Indego exoskeleton quickly and can manage a variety of surfaces. Walking speeds and distances achieved also indicate that some individuals with paraplegia can quickly become limited community ambulators using this system.

Indexed as

Exoskeleton DeviceWalkingAdolescentAdultEquipment DesignFemaleHumansMaleMiddle AgedParaplegiaPilot ProjectsQuadriplegiaSpinal Cord InjuriesTreatment OutcomeYoung Adultmobility limitationorthotic devicesrehabilitationroboticsspinal cord injurieswalking

Identifiers

PMID26364278
PMCPMC4568090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.